News & Updates
The latest news and updates from companies in the WLTH portfolio.
SpaceX stock falls below IPO price, testing investor confidence after blockbuster debut
SpaceX's slip below its initial public offering price risks turning a marquee stock-market debut into a confidence test, potentially unsettling retail investors and complicating decisions for other companies weighing high-profile listings. Elon Musk's company, spanning rockets to AI, debuted on June 12 and soared in the ensuing days, at one point valuing the company at well above $2 trillion. Since its debut, trading has been rocky. The stock slipped below its $150 opening price in late June with concerns about lofty tech stock valuations weighing on global indexes. The stock slid below its $135 IPO price for the first time on Wednesday, touching an intraday low of $132.15 before recovering to trade down 0.6% at $135.27 -- just over a month after the record-breaking IPO made Musk the world's first trillionaire. SpaceX shares started trading as part of the Nasdaq 100 index about a week ago. A break below the IPO price is a psychological blow for SpaceX shares, said Matthew Maley, chief market strategist at Miller Tabak. "It raises the narrative that the stock is up on fluff, on speculation, on froth, and not on real fundamentals," Maley said. Investors who bought into the excitement around SpaceX's listing, "hoping to 'make a killing' will be disappointed," said Greg Halter, director of research at Carnegie Investment Counsel. He said weakness in SpaceX would put it more in line with 30 years of heavily hyped IPOs, where average and median returns over the first month are often negative. SpaceX did not respond to a request for comment. PRICE DISCOVERY NOT PANIC? A drop below the IPO price is not unusual for a newly listed company. Shares of Cerebras Systems, which went public in May, have dropped below the IPO price, and Meta, formerly known as Facebook, fell similarly after its debut. Investors often fixate on IPO prices and early trading, said Ryan Lee, senior vice president of product and strategy at financial services firm Direxion. "The reality is, (SpaceX) is still undergoing some of this price discovery process," Lee said. A fall for SpaceX below $135 reflects "normal, albeit painful" market mechanics, especially as investors, venture capitalists and employees sell shares after lockups expire, said Gabriel Shahin, CEO at Falcon Wealth Planning. "A near-term dip below the $135 threshold would not fundamentally alter our current positioning or cause us to panic-sell," he said. CAUTION OR GREEN LIGHT FOR NEXT IPOS Some investors think SpaceX's stock performance could influence the market for future public listings. OpenAI and Anthropic are eyeing the public markets. Neither company responded to a request for comment. Carnegie's Halter said companies and investment banks considering large IPOs this year are watching SpaceX closely. "No one wants an IPO to flop or have the initial price be ratcheted down," Halter said. He suspects some IPOs would be pulled rather than priced at lower valuations. But Direxion's Lee said SpaceX's capital raise could encourage some companies with large funding needs to move faster. "If I'm OpenAI or if I'm Anthropic and I'm in this true arms race to build the frontier AI model and I need capital, I'm going to try to beat the other one out the door," Lee said. RISKING RETAIL TRADERS' SKEPTICISM A drop below the IPO price could hit retail investors, who received about 20% of the allocation, hard. "Many novice investors have approached SpaceX with a 'meme stock' mentality, buying in with capital they cannot afford to lose," Shahin said, warning that losses could fuel perceptions that markets favor insiders. "The market needs to understand that post-IPO volatility is normal." SpaceX's first earnings report will be a major test for the stock. Underwriters typically support stocks in the first 30 days and may do more for SpaceX given the deal's size, the public attention and the fact other high-profile offerings are imminent, said Maria Llerena, director of financial research at Domini Impact Investments. "Loss-making companies without a clear path to profitability are typically volatile and can fall below their IPO price," said Llerena. Published on July 16, 2026
Cerebras CEO Andrew Feldman Says Elon Musk Found a 'Pretty Good Idea' in Leasing SpaceXAI's Unused Grok Capacity to Anthropic
Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Cerebras Systems Inc. CEO Andrew Feldman says SpaceXAI, formerly xAI, moved into rented AI computing because its processors were not busy enough, as Grok drew less usage than expected. Feldman Blames Grok's Weak Early Adoption Speaking with Molly O'Shea on the Sourcery podcast on Monday, Feldman explained that Musk's company pivoted to an operator that rents out AI infrastructure because its Grok model struggled with early enterprise market adoption, leaving billions of dollars in hardware sitting idle. "You have to ask why they had available capacity," Feldman said. "They had available capacity because the Grok model wasn't used very much." Cerebras CEO @andrewdfeldman explains why @elonmusk and SpaceXAI made a deal to lease GPUs to Anthropic: "You have to ask why they had available capacity... They had available capacity because the Grok model wasn't used very much." "They had these GPUs sitting around, and... https://t.co/1IHsE98NR3 pic.twitter.com/ssomhhLJJl -- sourcery (@sourceryy) July 13, 2026 Trending: Avoid the #1 Investing Mistake: How Your 'Safe' Holdings Could Be Costing You Big Time Feldman said SpaceXAI could not afford to leave equipment idle. "They had these GPUs sitting around, and that's a bad idea," he said. He pointed to IPO-bound Anthropic's agreement to use SpaceX's Colossus 1 data center in Memphis, Tennessee. Anthropic said the site provides more than 300 megawatts through over 220,000 Nvidia GPUs, allowing it to double Claude Code limits, remove peak-hour reductions and raise API ceilings. "They leased a whole block of them to Anthropic, and looked up and said, 'Whoa, that's a pretty good idea,'" Feldman said. "We had all these GPUs. Our model wasn't a success, but we can have a great business by stepping into what is a constrained market." Anthropic Deal Monetizes Idle GPU Capacity In May, Anthropic agreed to pay $1.25 billion per month for Colossus and Colossus II capacity through May 2029. Both sides can terminate with 90 days' notice, and Musk described the arrangement as a six-month lease, leaving its long-term value uncertain. See Also: Skip the Regrets: The Essential Retirement Tips Experts Wish Everyone Knew Earlier. Colossus 1 supported Grok's development, but Reuters described its capacity as unused prior to the Anthropic agreement. SpaceXAI said Grok 4.5 trained across tens of thousands of Nvidia GB300 processors.
SpaceX's slide risks turning blockbuster IPO into confidence test
NEW YORK -- SpaceX's slip close to its initial public offering price risks turning a marquee stock-market debut into a confidence test, potentially unsettling retail investors and complicating decisions for other companies weighing high-profile listings. Elon Musk's company, spanning rockets to AI, debuted on June 12 and soared in the ensuing days, at one point valuing the company at well above US$2 trillion. Since then, trading has been rocky. The stock has slipped below its $150 opening price, but remained above the $135 offer price, with concerns about lofty tech stock valuations continuing to weigh on global indexes. SpaceX shares are at risk of falling below that level. They ended on Tuesday down 2.2 per cent at $136.08, their lowest closing level since the IPO, a week after they started trading as part of the Nasdaq 100 index. The stock dipped as low as $135.52. A break below the IPO price would be a psychological blow for SpaceX shares, said Matthew Maley, chief market strategist at Miller Tabak. "It raises the narrative that the stock is up on fluff, on speculation, on froth, and not on real fundamentals," Maley said. Investors who bought into the excitement around SpaceX's listing, "hoping to 'make a killing' will be disappointed," said Greg Halter, director of research at Carnegie Investment Counsel. He said weakness in SpaceX would put it more in line with 30 years of heavily hyped IPOs, where average and median returns over the first month are often negative. SpaceX did not immediately respond to a request for comment. Price discovery not panic? A drop below the IPO price would not be unusual for a newly listed company. Shares of Cerebras Systems, which went public in May, have dropped below the IPO price, and Meta, formerly known as Facebook, fell similarly after its debut. Investors often fixate on IPO prices and early trading, said Ryan Lee, senior vice president of product and strategy at financial services firm Direxion. "The reality is, (SpaceX) is still undergoing some of this price discovery process," Lee said. A fall for SpaceX below $135 would reflect "normal, albeit painful" market mechanics, especially as investors, venture capitalists and employees sell shares after lockups expire, said Gabriel Shahin, CEO at Falcon Wealth Planning. "A near-term dip below the $135 threshold would not fundamentally alter our current positioning or cause us to panic-sell," he said. Caution or green light for next IPOs? Some investors think SpaceX's stock performance could influence the market for future public listings. OpenAI and Anthropic are eyeing the public markets. Neither company responded to a request for comment. Carnegie's Halter said companies and investment banks considering large IPOs this year are watching SpaceX closely. "No one wants an IPO to flop or have the initial price be ratcheted down," Halter said. He suspects some IPOs would be pulled rather than priced at lower valuations. But Direxion's Lee said SpaceX's capital raise could encourage some companies with large funding needs to move faster. "If I'm OpenAI or if I'm Anthropic and I'm in this true arms race to build the frontier AI model and I need capital, I'm going to try to beat the other one out the door," Lee said. Risking retail traders' skepticism A drop below the IPO price could hit retail investors, who received about 20 per cent of the allocation, hard. "Many novice investors have approached SpaceX with a 'meme stock' mentality, buying in with capital they cannot afford to lose," Shahin said, warning that losses could fuel perceptions that markets favor insiders. "The market needs to understand that post-IPO volatility is normal." SpaceX's first earnings report will be a major test for the stock. Underwriters typically support stocks in the first 30 days and may do more for SpaceX given the deal's size, the public attention and the fact other high-profile offerings are imminent, said Maria Llerena, director of financial research at Domini Impact Investments. "Loss-making companies without a clear path to profitability are typically volatile and can fall below their IPO price," said Llerena.
SpaceX's slide risks turning blockbuster IPO into confidence test
NEW YORK, July 15 (Reuters) - SpaceX's slip close to its initial public offering price risks turning a marquee stock-market debut into a confidence test, potentially unsettling retail investors and complicating decisions for other companies weighing high-profile listings. Elon Musk's company, spanning rockets to AI, debuted on June 12 and soared in the ensuing days, at one point valuing the company at well above $2 trillion. Since then, trading has been rocky. The stock has slipped below its $150 opening price, but remained above the $135 offer price, with concerns about lofty tech stock valuations continuing to weigh on global indexes. SpaceX shares are at risk of falling below that level. They ended on Tuesday down 2.2% at $136.08, their lowest closing level since the IPO, a week after they started trading as part of the Nasdaq 100 index <.NDX>. The stock dipped as low as $135.52. A break below the IPO price would be a psychological blow for SpaceX shares, said Matthew Maley, chief market strategist at Miller Tabak. "It raises the narrative that the stock is up on fluff, on speculation, on froth, and not on real fundamentals," Maley said. Investors who bought into the excitement around SpaceX's listing, "hoping to 'make a killing' will be disappointed," said Greg Halter, director of research at Carnegie Investment Counsel. He said weakness in SpaceX would put it more in line with 30 years of heavily hyped IPOs, where average and median returns over the first month are often negative. SpaceX did not immediately respond to a request for comment. PRICE DISCOVERY NOT PANIC? A drop below the IPO price would not be unusual for a newly listed company. Shares of Cerebras Systems, which went public in May, have dropped below the IPO price, and Meta, formerly known as Facebook, fell similarly after its debut. Investors often fixate on IPO prices and early trading, said Ryan Lee, senior vice president of product and strategy at financial services firm Direxion. "The reality is, (SpaceX) is still undergoing some of this price discovery process," Lee said. A fall for SpaceX below $135 would reflect "normal, albeit painful" market mechanics, especially as investors, venture capitalists and employees sell shares after lockups expire, said Gabriel Shahin, CEO at Falcon Wealth Planning. "A near-term dip below the $135 threshold would not fundamentally alter our current positioning or cause us to panic-sell," he said. CAUTION OR GREEN LIGHT FOR NEXT IPOS Some investors think SpaceX's stock performance could influence the market for future public listings. OpenAI and Anthropic are eyeing the public markets. Neither company responded to a request for comment. Carnegie's Halter said companies and investment banks considering large IPOs this year are watching SpaceX closely. "No one wants an IPO to flop or have the initial price be ratcheted down," Halter said. He suspects some IPOs would be pulled rather than priced at lower valuations. But Direxion's Lee said SpaceX's capital raise could encourage some companies with large funding needs to move faster. "If I'm OpenAI or if I'm Anthropic and I'm in this true arms race to build the frontier AI model and I need capital, I'm going to try to beat the other one out the door," Lee said. RISKING RETAIL TRADERS' SKEPTICISM A drop below the IPO price could hit retail investors, who received about 20% of the allocation, hard. "Many novice investors have approached SpaceX with a 'meme stock' mentality, buying in with capital they cannot afford to lose," Shahin said, warning that losses could fuel perceptions that markets favor insiders. "The market needs to understand that post-IPO volatility is normal." SpaceX's first earnings report will be a major test for the stock. Underwriters typically support stocks in the first 30 days and may do more for SpaceX given the deal's size, the public attention and the fact other high-profile offerings are imminent, said Maria Llerena, director of financial research at Domini Impact Investments. "Loss-making companies without a clear path to profitability are typically volatile and can fall below their IPO price," said Llerena. (Reporting by Laura Matthews in New York; Additional reporting by Lewis Krauskopf in New York; editing by Megan Davies and Rod Nickel)
SpaceX's slide risks turning blockbuster IPO into confidence test - AOL
NEW YORK, July 15 (Reuters) - SpaceX's slip close to its initial public offering price risks turning a marquee stock-market debut into a confidence test, potentially unsettling retail investors and complicating decisions for other companies weighing high-profile listings. Elon Musk's company, spanning rockets to AI, debuted on June 12 and soared in the ensuing days, at one point valuing the company at well above $2 trillion. Since then, trading has been rocky. The stock has slipped below its $150 opening price, but remained above the $135 offer price, with concerns about lofty tech stock valuations continuing to weigh on global indexes. SpaceX shares are at risk of falling below that level. They ended on Tuesday down 2.2% at $136.08, their lowest closing level since the IPO, a week after they started trading as part of the Nasdaq 100 index <.NDX>. The stock dipped as low as $135.52. A break below the IPO price would be a psychological blow for SpaceX shares, said Matthew Maley, chief market strategist at Miller Tabak. "It raises the narrative that the stock is up on fluff, on speculation, on froth, and not on real fundamentals," Maley said. Investors who bought into the excitement around SpaceX's listing, "hoping to 'make a killing' will be disappointed," said Greg Halter, director of research at Carnegie Investment Counsel. He said weakness in SpaceX would put it more in line with 30 years of heavily hyped IPOs, where average and median returns over the first month are often negative. SpaceX did not immediately respond to a request for comment. PRICE DISCOVERY NOT PANIC? A drop below the IPO price would not be unusual for a newly listed company. Shares of Cerebras Systems, which went public in May, have dropped below the IPO price, and Meta, formerly known as Facebook, fell similarly after its debut. Investors often fixate on IPO prices and early trading, said Ryan Lee, senior vice president of product and strategy at financial services firm Direxion. "The reality is, (SpaceX) is still undergoing some of this price discovery process," Lee said. A fall for SpaceX below $135 would reflect "normal, albeit painful" market mechanics, especially as investors, venture capitalists and employees sell shares after lockups expire, said Gabriel Shahin, CEO at Falcon Wealth Planning. "A near-term dip below the $135 threshold would not fundamentally alter our current positioning or cause us to panic-sell," he said. CAUTION OR GREEN LIGHT FOR NEXT IPOS Some investors think SpaceX's stock performance could influence the market for future public listings. OpenAI and Anthropic are eyeing the public markets. Neither company responded to a request for comment. Carnegie's Halter said companies and investment banks considering large IPOs this year are watching SpaceX closely. "No one wants an IPO to flop or have the initial price be ratcheted down," Halter said. He suspects some IPOs would be pulled rather than priced at lower valuations. But Direxion's Lee said SpaceX's capital raise could encourage some companies with large funding needs to move faster. "If I'm OpenAI or if I'm Anthropic and I'm in this true arms race to build the frontier AI model and I need capital, I'm going to try to beat the other one out the door," Lee said. RISKING RETAIL TRADERS' SKEPTICISM A drop below the IPO price could hit retail investors, who received about 20% of the allocation, hard. "Many novice investors have approached SpaceX with a 'meme stock' mentality, buying in with capital they cannot afford to lose," Shahin said, warning that losses could fuel perceptions that markets favor insiders. "The market needs to understand that post-IPO volatility is normal." SpaceX's first earnings report will be a major test for the stock. Underwriters typically support stocks in the first 30 days and may do more for SpaceX given the deal's size, the public attention and the fact other high-profile offerings are imminent, said Maria Llerena, director of financial research at Domini Impact Investments. "Loss-making companies without a clear path to profitability are typically volatile and can fall below their IPO price," said Llerena. (Reporting by Laura Matthews in New York; Additional reporting by Lewis Krauskopf in New York; editing by Megan Davies and Rod Nickel)
SpaceX's slide risks turning blockbuster IPO into confidence test
NEW YORK, July 15 (Reuters) - SpaceX's (SPCX.O), opens new tab slip close to its initial public offering price risks turning a marquee stock-market debut into a confidence test, potentially unsettling retail investors and complicating decisions for other companies weighing high-profile listings. Elon Musk's company, spanning rockets to AI, debuted on June 12 and soared in the ensuing days, at one point valuing the company at well above $2 trillion. Since then, trading has been rocky. The stock has slipped below its $150 opening price, but remained above the $135 offer price, with concerns about lofty tech stock valuations continuing to weigh on global indexes. SpaceX shares are at risk of falling below that level. They ended on Tuesday down 2.2% at $136.08, their lowest closing level since the IPO, a week after they started trading as part of the Nasdaq 100 index <.NDX, opens new tab>. The stock dipped as low as $135.52. A break below the IPO price would be a psychological blow for SpaceX shares, said Matthew Maley, chief market strategist at Miller Tabak. "It raises the narrative that the stock is up on fluff, on speculation, on froth, and not on real fundamentals," Maley said. Investors who bought into the excitement around SpaceX's listing, "hoping to 'make a killing' will be disappointed," said Greg Halter, director of research at Carnegie Investment Counsel. He said weakness in SpaceX would put it more in line with 30 years of heavily hyped IPOs, where average and median returns over the first month are often negative. SpaceX did not immediately respond to a request for comment. PRICE DISCOVERY NOT PANIC? A drop below the IPO price would not be unusual for a newly listed company. Shares of Cerebras Systems, which went public in May, have dropped below the IPO price, and Meta, formerly known as Facebook, fell similarly after its debut. Investors often fixate on IPO prices and early trading, said Ryan Lee, senior vice president of product and strategy at financial services firm Direxion. "The reality is, (SpaceX) is still undergoing some of this price discovery process," Lee said. A fall for SpaceX below $135 would reflect "normal, albeit painful" market mechanics, especially as investors, venture capitalists and employees sell shares after lockups expire, said Gabriel Shahin, CEO at Falcon Wealth Planning. "A near-term dip below the $135 threshold would not fundamentally alter our current positioning or cause us to panic-sell," he said. CAUTION OR GREEN LIGHT FOR NEXT IPOS Some investors think SpaceX's stock performance could influence the market for future public listings. OpenAI and Anthropic are eyeing the public markets. Neither company responded to a request for comment. Carnegie's Halter said companies and investment banks considering large IPOs this year are watching SpaceX closely. "No one wants an IPO to flop or have the initial price be ratcheted down," Halter said. He suspects some IPOs would be pulled rather than priced at lower valuations. But Direxion's Lee said SpaceX's capital raise could encourage some companies with large funding needs to move faster. "If I'm OpenAI or if I'm Anthropic and I'm in this true arms race to build the frontier AI model and I need capital, I'm going to try to beat the other one out the door," Lee said. RISKING RETAIL TRADERS' SKEPTICISM A drop below the IPO price could hit retail investors, who received about 20% of the allocation, hard. "Many novice investors have approached SpaceX with a 'meme stock' mentality, buying in with capital they cannot afford to lose," Shahin said, warning that losses could fuel perceptions that markets favor insiders. "The market needs to understand that post-IPO volatility is normal." SpaceX's first earnings report will be a major test for the stock. Underwriters typically support stocks in the first 30 days and may do more for SpaceX given the deal's size, the public attention and the fact other high-profile offerings are imminent, said Maria Llerena, director of financial research at Domini Impact Investments. "Loss-making companies without a clear path to profitability are typically volatile and can fall below their IPO price," said Llerena. Reporting by Laura Matthews in New York; Additional reporting by Lewis Krauskopf in New York; editing by Megan Davies and Rod Nickel Our Standards: The Thomson Reuters Trust Principles., opens new tab
SpaceX's slide risks turning blockbuster IPO into confidence test
SpaceX's (SPCX-Q) slip close to its initial public offering price risks turning a marquee stock-market debut into a confidence test, potentially unsettling retail investors and complicating decisions for other companies weighing high-profile listings. Elon Musk's company, spanning rockets to AI, debuted on June 12 and soared in the ensuing days, at one point valuing the company at well above US$2-trillion. Since then, trading has been rocky. The stock has slipped below its US$150 opening price, but remained above the US$135 offer price, with concerns about lofty tech stock valuations continuing to weigh on global indexes. SpaceX shares are at risk of falling below that level. They ended on Tuesday down 2.2 per cent at US$136.08, their lowest closing level since the IPO, a week after they started trading as part of the Nasdaq 100 index. The stock dipped as low as US$135.52. A break below the IPO price would be a psychological blow for SpaceX shares, said Matthew Maley, chief market strategist at Miller Tabak. "It raises the narrative that the stock is up on fluff, on speculation, on froth, and not on real fundamentals," Maley said. Investors who bought into the excitement around SpaceX's listing, "hoping to 'make a killing' will be disappointed," said Greg Halter, director of research at Carnegie Investment Counsel. He said weakness in SpaceX would put it more in line with 30 years of heavily hyped IPOs, where average and median returns over the first month are often negative. SpaceX did not immediately respond to a request for comment. A drop below the IPO price would not be unusual for a newly listed company. Shares of Cerebras Systems, which went public in May, have dropped below the IPO price, and Meta, formerly known as Facebook, fell similarly after its debut. Investors often fixate on IPO prices and early trading, said Ryan Lee, senior vice president of product and strategy at financial services firm Direxion. "The reality is, (SpaceX) is still undergoing some of this price discovery process," Lee said. A fall for SpaceX below US$135 would reflect "normal, albeit painful" market mechanics, especially as investors, venture capitalists and employees sell shares after lockups expire, said Gabriel Shahin, CEO at Falcon Wealth Planning. "A near-term dip below the US$135 threshold would not fundamentally alter our current positioning or cause us to panic-sell," he said. Some investors think SpaceX's stock performance could influence the market for future public listings. OpenAI and Anthropic are eyeing the public markets. Neither company responded to a request for comment. Carnegie's Halter said companies and investment banks considering large IPOs this year are watching SpaceX closely. "No one wants an IPO to flop or have the initial price be ratcheted down," Halter said. He suspects some IPOs would be pulled rather than priced at lower valuations. But Direxion's Lee said SpaceX's capital raise could encourage some companies with large funding needs to move faster. "If I'm OpenAI or if I'm Anthropic and I'm in this true arms race to build the frontier AI model and I need capital, I'm going to try to beat the other one out the door," Lee said. A drop below the IPO price could hit retail investors, who received about 20 per cent of the allocation, hard. "Many novice investors have approached SpaceX with a 'meme stock' mentality, buying in with capital they cannot afford to lose," Shahin said, warning that losses could fuel perceptions that markets favor insiders. "The market needs to understand that post-IPO volatility is normal." SpaceX's first earnings report will be a major test for the stock. Underwriters typically support stocks in the first 30 days and may do more for SpaceX given the deal's size, the public attention and the fact other high-profile offerings are imminent, said Maria Llerena, director of financial research at Domini Impact Investments. "Loss-making companies without a clear path to profitability are typically volatile and can fall below their IPO price," said Llerena.
SpaceX's slide risks turning blockbuster IPO into confidence test By Reuters
NEW YORK, July 15 (Reuters) - SpaceX's slip close to its initial public offering price risks turning a marquee stock-market debut into a confidence test, potentially unsettling retail investors and complicating decisions for other companies weighing high-profile listings. Elon Musk's company, spanning rockets to AI, debuted on June 12 and soared in the ensuing days, at one point valuing the company at well above $2 trillion. Since then, trading has been rocky. The stock has slipped below its $150 opening price, but remained above the $135 offer price, with concerns about lofty tech stock valuations continuing to weigh on global indexes. SpaceX shares are at risk of falling below that level. They ended on Tuesday down 2.2% at $136.08, their lowest closing level since the IPO, a week after they started trading as part of the Nasdaq 100 index (NDX). The stock dipped as low as $135.52. A break below the IPO price would be a psychological blow for SpaceX shares, said Matthew Maley, chief market strategist at Miller Tabak. "It raises the narrative that the stock is up on fluff, on speculation, on froth, and not on real fundamentals," Maley said. Investors who bought into the excitement around SpaceX's listing, "hoping to 'make a killing' will be disappointed," said Greg Halter, director of research at Carnegie Investment Counsel. He said weakness in SpaceX would put it more in line with 30 years of heavily hyped IPOs, where average and median returns over the first month are often negative. SpaceX did not immediately respond to a request for comment. PRICE DISCOVERY NOT PANIC? A drop below the IPO price would not be unusual for a newly listed company. Shares of Cerebras Systems, which went public in May, have dropped below the IPO price, and Meta, formerly known as Facebook, fell similarly after its debut. Investors often fixate on IPO prices and early trading, said Ryan Lee, senior vice president of product and strategy at financial services firm Direxion. "The reality is, (SpaceX) is still undergoing some of this price discovery process," Lee said. A fall for SpaceX below $135 would reflect "normal, albeit painful" market mechanics, especially as investors, venture capitalists and employees sell shares after lockups expire, said Gabriel Shahin, CEO at Falcon Wealth Planning. "A near-term dip below the $135 threshold would not fundamentally alter our current positioning or cause us to panic-sell," he said. CAUTION OR GREEN LIGHT FOR NEXT IPOS Some investors think SpaceX's stock performance could influence the market for future public listings. OpenAI and Anthropic are eyeing the public markets. Neither company responded to a request for comment. Carnegie's Halter said companies and investment banks considering large IPOs this year are watching SpaceX closely. "No one wants an IPO to flop or have the initial price be ratcheted down," Halter said. He suspects some IPOs would be pulled rather than priced at lower valuations. But Direxion's Lee said SpaceX's capital raise could encourage some companies with large funding needs to move faster. "If I'm OpenAI or if I'm Anthropic and I'm in this true arms race to build the frontier AI model and I need capital, I'm going to try to beat the other one out the door," Lee said. RISKING RETAIL TRADERS' SKEPTICISM A drop below the IPO price could hit retail investors, who received about 20% of the allocation, hard. "Many novice investors have approached SpaceX with a 'meme stock' mentality, buying in with capital they cannot afford to lose," Shahin said, warning that losses could fuel perceptions that markets favor insiders. "The market needs to understand that post-IPO volatility is normal." SpaceX's first earnings report will be a major test for the stock. Underwriters typically support stocks in the first 30 days and may do more for SpaceX given the deal's size, the public attention and the fact other high-profile offerings are imminent, said Maria Llerena, director of financial research at Domini Impact Investments. "Loss-making companies without a clear path to profitability are typically volatile and can fall below their IPO price," said Llerena.
SpaceX IPO Wobbles: Market Confidence Tested as Shares Slide
SpaceX's Slipping Share Price Turns IPO Into Test of Market Confidence Market Reaction to SpaceX's IPO Performance By Laura Matthews NEW YORK, July 15 (Reuters) - SpaceX's slip close to its initial public offering price risks turning a marquee stock-market debut into a confidence test, potentially unsettling retail investors and complicating decisions for other companies weighing high-profile listings. Elon Musk's company, spanning rockets to AI, debuted on June 12 and soared in the ensuing days, at one point valuing the company at well above $2 trillion. Since then, trading has been rocky. The stock has slipped below its $150 opening price, but remained above the $135 offer price, with concerns about lofty tech stock valuations continuing to weigh on global indexes. SpaceX shares are at risk of falling below that level. They ended on Tuesday down 2.2% at $136.08, their lowest closing level since the IPO, a week after they started trading as part of the Nasdaq 100 index <.NDX>. The stock dipped as low as $135.52. Investor Sentiment and Psychological Impact A break below the IPO price would be a psychological blow for SpaceX shares, said Matthew Maley, chief market strategist at Miller Tabak. "It raises the narrative that the stock is up on fluff, on speculation, on froth, and not on real fundamentals," Maley said. Investors who bought into the excitement around SpaceX's listing, "hoping to 'make a killing' will be disappointed," said Greg Halter, director of research at Carnegie Investment Counsel. He said weakness in SpaceX would put it more in line with 30 years of heavily hyped IPOs, where average and median returns over the first month are often negative. SpaceX did not immediately respond to a request for comment. Price Discovery and Market Mechanics PRICE DISCOVERY NOT PANIC? A drop below the IPO price would not be unusual for a newly listed company. Shares of Cerebras Systems, which went public in May, have dropped below the IPO price, and Meta, formerly known as Facebook, fell similarly after its debut. Investors often fixate on IPO prices and early trading, said Ryan Lee, senior vice president of product and strategy at financial services firm Direxion. "The reality is, (SpaceX) is still undergoing some of this price discovery process," Lee said. A fall for SpaceX below $135 would reflect "normal, albeit painful" market mechanics, especially as investors, venture capitalists and employees sell shares after lockups expire, said Gabriel Shahin, CEO at Falcon Wealth Planning. "A near-term dip below the $135 threshold would not fundamentally alter our current positioning or cause us to panic-sell," he said. Implications for Future IPOs CAUTION OR GREEN LIGHT FOR NEXT IPOS Some investors think SpaceX's stock performance could influence the market for future public listings. OpenAI and Anthropic are eyeing the public markets. Neither company responded to a request for comment. Carnegie's Halter said companies and investment banks considering large IPOs this year are watching SpaceX closely. "No one wants an IPO to flop or have the initial price be ratcheted down," Halter said. He suspects some IPOs would be pulled rather than priced at lower valuations. But Direxion's Lee said SpaceX's capital raise could encourage some companies with large funding needs to move faster. "If I'm OpenAI or if I'm Anthropic and I'm in this true arms race to build the frontier AI model and I need capital, I'm going to try to beat the other one out the door," Lee said. Retail Investors and Volatility Risks RISKING RETAIL TRADERS' SKEPTICISM A drop below the IPO price could hit retail investors, who received about 20% of the allocation, hard. "Many novice investors have approached SpaceX with a 'meme stock' mentality, buying in with capital they cannot afford to lose," Shahin said, warning that losses could fuel perceptions that markets favor insiders. "The market needs to understand that post-IPO volatility is normal." SpaceX's first earnings report will be a major test for the stock. Underwriters typically support stocks in the first 30 days and may do more for SpaceX given the deal's size, the public attention and the fact other high-profile offerings are imminent, said Maria Llerena, director of financial research at Domini Impact Investments. "Loss-making companies without a clear path to profitability are typically volatile and can fall below their IPO price," said Llerena. (Reporting by Laura Matthews in New York; Additional reporting by Lewis Krauskopf in New York; editing by Megan Davies and Rod Nickel)
Nvidia vs Cerebras: Which Is the Better Discount AI Buy Now?
Nvidia (NASDAQ: NVDA) and Cerebras Systems (NASDAQ: CBRS) both offer something in great need right now: the high-powered compute to fuel artificial intelligence (AI) workloads. Nvidia is the better-known of the two, having been in the chip space for more than 30 years, and today dominates the AI chip market. Cerebras is an exciting new player with a very powerful chip. Both of these companies could make an interesting investment, and they have seen their shares decline from highs in recent times. This presents a potential buying opportunity. But which is the better discount AI buy right now? Let's find out. Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue " Image source: Getty Images. The case for Nvidia Nvidia hardly needs an introduction these days. The company has made headlines since the start of the AI boom as its comments set the tone for what happens next in this market. Nvidia designs the world's most sought-after graphics processing units (GPUs), the key chips needed to power essential tasks like the training and inference of models. The company was first to enter this market and has made innovation a focus -- that's helped it stay ahead of rivals. In fact, Nvidia updates its GPUs on an annual basis, and the next update is right around the corner. The company aims to ship its Vera Rubin platform later this year, and it will offer an important new product: the stand-alone central processing unit (CPU). This opens up a new $200 billion market to Nvidia, and the company plans on conquering it. In its latest earnings report, it predicted $20 billion in stand-alone CPU sales this year and said it was on track to dominate this market. Meanwhile, Nvidia has proven its strength over time, and in recent years has delivered quarter after quarter of double- or triple-digit earnings gains. And earnings have reached record levels amid this AI boom. All of this is likely to continue, considering the sustained level of demand and the idea that AI is in its early days of real-world use. The case for Cerebras Cerebras may not be a household name like Nvidia, but the company's technology might quickly put it on the radar screens of many investors. This player has designed a giant chip, its wafer-scale engine (WSE), that it says delivers speeds faster than today's GPUs. How has Cerebras accomplished this? By making the WSE 58 times larger than Nvidia's B200 chip. Cerebras says that this size allows it to offer massive compute and memory bandwidth, and this results in tremendous speed. The company says that in inference, or the thinking AI goes through to solve a problem, it's delivered answers 15 times faster than today's top-selling GPUs. This has translated into growth for Cerebras, with first-quarter revenue soaring 92% to $193 million. And the company recently signed key deals with OpenAI for compute and with Amazon's cloud unit to make its WSE systems more broadly available. So this could be a major transition point for Cerebras, as more potential customers discover its chips and give them a try. It's important to note that, considering the high level of demand for compute, Cerebras doesn't have to unseat Nvidia in order to be highly successful and deliver strong growth. Analysts predict the AI market will reach beyond $3 trillion in the early part of the next decade, and this should create a strong revenue opportunity for many chip players. This young company, founded in 2015, went public in May, raising $5.5 billion in the biggest IPO of 2025 -- until Space Exploration Technologies launched its operation in June, for the largest IPO ever. The market leader or the young challenger? Cerebras isn't yet profitable, which isn't surprising at this stage of its growth story, but this adds to risk. The stock has slid 30% from its first day of trading, offering an interesting buying opportunity for aggressive investors. But for most investors, I consider Nvidia the best discount AI buy today. The AI giant is trading at 23x forward earnings estimates, which looks like a steal considering all of the company's strengths. Should you buy stock in Nvidia right now? Before you buy stock in Nvidia, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now... and Nvidia wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $398,160!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,249,202!* Now, it's worth noting Stock Advisor's total average return is 918% -- a market-crushing outperformance compared to 209% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors. See the 10 stocks " *Stock Advisor returns as of July 15, 2026. Adria Cimino has positions in Amazon. The Motley Fool has positions in and recommends Amazon and Nvidia. The Motley Fool has a disclosure policy. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Nvidia vs Cerebras: Which Is the Better Discount AI Buy Now?
Nvidia (NASDAQ: NVDA) and Cerebras Systems (NASDAQ: CBRS) both offer something in great need right now: the high-powered compute to fuel artificial intelligence (AI) workloads. Nvidia is the better-known of the two, having been in the chip space for more than 30 years, and today dominates the AI chip market. Cerebras is an exciting new player with a very powerful chip. Both of these companies could make an interesting investment, and they have seen their shares decline from highs in recent times. This presents a potential buying opportunity. But which is the better discount AI buy right now? Let's find out. Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue " The case for Nvidia Nvidia hardly needs an introduction these days. The company has made headlines since the start of the AI boom as its comments set the tone for what happens next in this market. Nvidia designs the world's most sought-after graphics processing units (GPUs), the key chips needed to power essential tasks like the training and inference of models. The company was first to enter this market and has made innovation a focus -- that's helped it stay ahead of rivals. In fact, Nvidia updates its GPUs on an annual basis, and the next update is right around the corner. The company aims to ship its Vera Rubin platform later this year, and it will offer an important new product: the stand-alone central processing unit (CPU). This opens up a new $200 billion market to Nvidia, and the company plans on conquering it. In its latest earnings report, it predicted $20 billion in stand-alone CPU sales this year and said it was on track to dominate this market. Meanwhile, Nvidia has proven its strength over time, and in recent years has delivered quarter after quarter of double- or triple-digit earnings gains. And earnings have reached record levels amid this AI boom. All of this is likely to continue, considering the sustained level of demand and the idea that AI is in its early days of real-world use. The case for Cerebras Cerebras may not be a household name like Nvidia, but the company's technology might quickly put it on the radar screens of many investors. This player has designed a giant chip, its wafer-scale engine (WSE), that it says delivers speeds faster than today's GPUs. How has Cerebras accomplished this? By making the WSE 58 times larger than Nvidia's B200 chip.
Nvidia vs Cerebras: which discounted AI chip stock offers better value right now
Both AI hardware giants are trading below their peak valuations, but the investment cases could not be more different. Nvidia, the undisputed king of GPU-powered AI training, trades at roughly 28x forward earnings. Cerebras, the scrappy newcomer with wafer-scale chips the size of dinner plates, is still finding its footing after a blockbuster IPO. The question isn't whether AI chips matter. It's which bet makes more sense at today's prices. The tale of the tape Cerebras Systems hit public markets on May 14, 2026, pricing its IPO at $185 per share and raising $5.55 billion in the process. The stock surged 68% on its first day of trading, briefly pushing the company's market cap near $100 billion. Shares have been bouncing between $226 and $230 in late June, a significant pullback from debut highs. Cerebras reported $510 million in revenue for 2025, a 76% year-over-year increase. The company guided 2026 revenue between $855 million and $865 million, slightly above what analysts had penciled in. It also disclosed a backlog worth $24.6 billion. Nvidia's forward earnings multiple of around 28x actually looks reasonable by AI-era standards, and some analyst models peg its intrinsic value near $323 per share, suggesting the stock could be roughly 30% undervalued at current levels. Different chips, different bets Cerebras' WSE-3 wafer-scale chips are reportedly 57 times larger than Nvidia's biggest GPUs. The company claims performance up to 21 times faster than comparable Nvidia hardware, at approximately one-third lower cost versus Nvidia's Blackwell B200 chips. OpenAI accounts for about 24% of Cerebras' revenue and backlog. Having nearly a quarter of your business tied to a single customer is the definition of concentration risk. Nvidia controls approximately 80% of the AI data-center GPU market. Its CUDA software platform has created a moat that extends far beyond raw chip performance. Why crypto investors should care Companies like Core Scientific and Hut 8 have already pivoted toward AI hosting, essentially renting out their data center capacity to AI workloads that can pay more than Bitcoin mining. For investors weighing these two stocks as portfolio positions, the risk profiles are starkly different. Nvidia offers what looks like a discounted entry into a proven cash-flow machine with dominant market share. At 28x forward earnings with analysts suggesting 30% upside to intrinsic value, it's the kind of setup that appeals to investors who want AI exposure without stomach-churning volatility. Cerebras is the higher-variance play. A $24.6 billion backlog and 76% revenue growth are impressive, but the stock has already demonstrated it can move violently in both directions. Revenue guidance that came in only slightly above expectations suggests the market may have already priced in much of the near-term growth story. The OpenAI concentration issue deserves serious weight in any investment thesis. If that relationship deepens, Cerebras becomes a leveraged bet on OpenAI's continued dominance. If OpenAI diversifies its chip suppliers, that 24% revenue exposure becomes a vulnerability rather than a selling point.
Cerebras (CBRS) Makes a Massive Bet on Europe's AI Boom
With an upside potential of 60.19%, Cerebras Systems Inc. (NASDAQ:CBRS) is among the 12 Strong Buy Stocks with High Upside According to Analysts. On July 9, Cerebras Systems Inc. (NASDAQ:CBRS) announced a major expansion of its European infrastructure footprint, revealing plans to bring its first European data center capacity online by the end of 2026. The company intends to rapidly scale operations across France and the Nordic region, targeting a total capacity of 200 megawatts by the end of 2027. A portion of this infrastructure is expected to support workloads from OpenAI under the company's existing partnership. According to management, the expansion will place Cerebras' high-speed AI inference capabilities closer to European customers, addressing growing demand for locally hosted artificial intelligence compute resources while strengthening the company's global presence. Earlier, on June 30, Freedom Capital initiated coverage of Cerebras Systems Inc. (NASDAQ:CBRS) with a Hold rating and a $209 price target. The firm noted that the stock experienced significant volatility following first-quarter results, declining sharply and trading as low as $161. Despite highlighting meaningful operational risks associated with the company's rapid expansion strategy, Freedom Capital stated that the recent selloff has created a more attractive entry point for investors. The analyst believes the market may now be underappreciating the company's long-term opportunities within the AI infrastructure sector. Founded in 2015 and headquartered in Sunnyvale, California, Cerebras Systems Inc. (NASDAQ:CBRS) develops wafer-scale processors and artificial intelligence supercomputers designed to dramatically accelerate AI training and inference workloads. Its proprietary architecture enables customers to process complex AI models more efficiently, positioning the company as a differentiated provider of next-generation computing infrastructure. While we acknowledge the potential of CBRS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. Disclosure: None. Follow Insider Monkey on Google News.
Cerebras (CBRS) Makes a Massive Bet on Europe's AI Boom
With an upside potential of 60.19%, Cerebras Systems Inc. (NASDAQ:CBRS) is among the 12 Strong Buy Stocks with High Upside According to Analysts. On July 9, Cerebras Systems Inc. (NASDAQ:CBRS) announced a major expansion of its European infrastructure footprint, revealing plans to bring its first European data center capacity online by the end of 2026. The company intends to rapidly scale operations across France and the Nordic region, targeting a total capacity of 200 megawatts by the end of 2027. A portion of this infrastructure is expected to support workloads from OpenAI under the company's existing partnership. According to management, the expansion will place Cerebras' high-speed AI inference capabilities closer to European customers, addressing growing demand for locally hosted artificial intelligence compute resources while strengthening the company's global presence. Earlier, on June 30, Freedom Capital initiated coverage of Cerebras Systems Inc. (NASDAQ:CBRS) with a Hold rating and a $209 price target. The firm noted that the stock experienced significant volatility following first-quarter results, declining sharply and trading as low as $161. Despite highlighting meaningful operational risks associated with the company's rapid expansion strategy, Freedom Capital stated that the recent selloff has created a more attractive entry point for investors. The analyst believes the market may now be underappreciating the company's long-term opportunities within the AI infrastructure sector. Founded in 2015 and headquartered in Sunnyvale, California, Cerebras Systems Inc. (NASDAQ:CBRS) develops wafer-scale processors and artificial intelligence supercomputers designed to dramatically accelerate AI training and inference workloads. Its proprietary architecture enables customers to process complex AI models more efficiently, positioning the company as a differentiated provider of next-generation computing infrastructure. While we acknowledge the potential of CBRS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. Disclosure: None. Follow Insider Monkey on Google News.
Nvidia vs Cerebras: Which Is the Better Discount AI Buy Now?
Nvidia (NVDA +4.08%) and Cerebras Systems (CBRS 0.40%) both offer something in great need right now: the high-powered compute to fuel artificial intelligence (AI) workloads. Nvidia is the better-known of the two, having been in the chip space for more than 30 years, and today dominates the AI chip market. Cerebras is an exciting new player with a very powerful chip. Both of these companies could make an interesting investment, and they have seen their shares decline from highs in recent times. This presents a potential buying opportunity. But which is the better discount AI buy right now? Let's find out. The case for Nvidia Nvidia hardly needs an introduction these days. The company has made headlines since the start of the AI boom as its comments set the tone for what happens next in this market. Nvidia designs the world's most sought-after graphics processing units (GPUs), the key chips needed to power essential tasks like the training and inference of models. The company was first to enter this market and has made innovation a focus -- that's helped it stay ahead of rivals. In fact, Nvidia updates its GPUs on an annual basis, and the next update is right around the corner. The company aims to ship its Vera Rubin platform later this year, and it will offer an important new product: the stand-alone central processing unit (CPU). This opens up a new $200 billion market to Nvidia, and the company plans on conquering it. In its latest earnings report, it predicted $20 billion in stand-alone CPU sales this year and said it was on track to dominate this market. Meanwhile, Nvidia has proven its strength over time, and in recent years has delivered quarter after quarter of double- or triple-digit earnings gains. And earnings have reached record levels amid this AI boom. All of this is likely to continue, considering the sustained level of demand and the idea that AI is in its early days of real-world use. The case for Cerebras Cerebras may not be a household name like Nvidia, but the company's technology might quickly put it on the radar screens of many investors. This player has designed a giant chip, its wafer-scale engine (WSE), that it says delivers speeds faster than today's GPUs. How has Cerebras accomplished this? By making the WSE 58 times larger than Nvidia's B200 chip. Cerebras says that this size allows it to offer massive compute and memory bandwidth, and this results in tremendous speed. The company says that in inference, or the thinking AI goes through to solve a problem, it's delivered answers 15 times faster than today's top-selling GPUs. This has translated into growth for Cerebras, with first-quarter revenue soaring 92% to $193 million. And the company recently signed key deals with OpenAI for compute and with Amazon's cloud unit to make its WSE systems more broadly available. So this could be a major transition point for Cerebras, as more potential customers discover its chips and give them a try. It's important to note that, considering the high level of demand for compute, Cerebras doesn't have to unseat Nvidia in order to be highly successful and deliver strong growth. Analysts predict the AI market will reach beyond $3 trillion in the early part of the next decade, and this should create a strong revenue opportunity for many chip players. This young company, founded in 2015, went public in May, raising $5.5 billion in the biggest IPO of 2025 -- until Space Exploration Technologies launched its operation in June, for the largest IPO ever. The market leader or the young challenger? Cerebras isn't yet profitable, which isn't surprising at this stage of its growth story, but this adds to risk. The stock has slid 30% from its first day of trading, offering an interesting buying opportunity for aggressive investors. But for most investors, I consider Nvidia the best discount AI buy today. The AI giant is trading at 23x forward earnings estimates, which looks like a steal considering all of the company's strengths.
Cerebras Stock: Strong Potential, But The Risk/Reward Doesn't Add Up (NASDAQ:CBRS) | Seeking Alpha
Despite ambitious international expansion and manufacturing scale-up, the forward P/S of 53.73 makes the risk/reward unattractive for new entry. A few years ago, OpenAI's (OPENAI) release of ChatGPT put the spotlight on parallel computing, particularly NVIDIA's (NVDA) GPUs. Since then, competing GPUs have been released, and some companies have been looking for other I'm a full-time investor with a strong focus on the tech sector. I graduated with a Bachelor of Commerce Degree with Distinction, major in Finance. I'm also a proud lifetime member of the Beta Gamma Sigma International Business Honor Society. My core values are: Excellence, Integrity, Transparency, & Respect. I always, to the best of my ability, hold true to these values which I believe are key for long-term success. I would like to invite all of my readers to leave their constructive criticism and feedback in the comments section so that I can further enhance the quality of my work moving forward. Thank you and God Bless America! Analyst's Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
SpaceX Just Changed the Rules for Every Future IPO. The Market is Now Eyeing These 2 Upcoming IPOs.
The first half of 2026 is over, and nothing has sparked more excitement on Wall Street than blockbuster initial public offerings (IPOs). Investors watched AI chipmaker Cerebras Systems (CBRS) make a stunning debut with its IPO in May, proving that demand for next-generation artificial intelligence (AI) companies remains exceptionally strong. Then came Elon Musk's SpaceX (SPCX), which has long been one of the world's most sought-after private companies. The long-awaited IPO became the largest in history. The company priced its offering at $135 per share on June 11 and began trading on the Nasdaq under the ticker SPCX on June 12, raising $75 billion at an initial valuation of roughly $1.77 trillion. The stock surged 19% on its debut, briefly lifting SpaceX's market cap above $2 trillion. However, shares have now pulled back amid broader concerns about lofty valuations and the company's aggressive spending plans. SPCX stock is still seeing quite a lot of volatility and is down another 6% as of this writing. It is presently trading just a little above its all-time low price. More News from Barchart These 2 Stocks Could Be Next Founded in 2002, SpaceX remained private for a long time. It repeatedly raised tens of billions from private investors and reached an enormous valuation before considering a public listing. After SpaceX's explosive entry, the market is now looking forward to OpenAI and Anthropic's IPOs. Both companies have taken the first formal step by confidentially filing the draft registration statements with the U.S. Securities and Exchange Commission (SEC). A confidential filing lets a company start the IPO review process while keeping its financial statements and offering details private until a later stage. OpenAI Is Taking a Patient Approach OpenAI is an AI company best known for ChatGPT. The company develops generative AI models and software that allow users and businesses to create content, write code, analyze data, and automate complex tasks. Earlier this month, OpenAI confirmed that it had confidentially filed for a U.S. IPO. However, more recently, Reuters reported that OpenAI is considering delaying its IPO until 2027 rather than rushing to market this year, as it seeks a valuation of up to $1 trillion. This could be because of recent investors' caution towards AI stocks that has led to a broader tech selloff. This decision aligns with SpaceX's strategy to remain private until it has reached enormous scale.
Here's What the Street Thinks About Cerebras Systems (CBRS)
Cerebras Systems Inc. (NASDAQ:CBRS) is one of the most promising future stocks to buy right now. Cerebras Systems Inc. (NASDAQ:CBRS) received several rating updates following the release of its strong fiscal Q1 2026 results. Morgan Stanley lifted the price target on the stock to $273 from $250 on June 24 and maintained an Overweight rating on the shares after what the firm called "a strong first quarter out of the gates". It further stated that although the IPO happened recently enough that the firm expected solid results with no surprises, and presumed some IPO conservatism built into forecasts, Morgan Stanley believes that the better gross margin guidance "certainly indicates a conservative guidance mindset." The same day, UBS lifted the price target on Cerebras Systems Inc. (NASDAQ:CBRS) to $320 from $300, maintaining a Buy rating on the shares and stating that the company's first post-IPO earnings call is viewed positively after raised guidance and confirmation of an Amazon (AMZN) agreement. It further told investors in a research note that broader customer diversification and accelerating demand for specialized infrastructure could support strong growth through the decade. Cerebras Systems Inc. (NASDAQ:CBRS) is involved in the design and provision of processors for AI training and inference. The company's products include AI model services, inference, Wafer Scale Engine, cloud, processors, and systems. While we acknowledge the potential of CBRS as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. Disclosure: None. Follow Insider Monkey on Google News.